AMENDED AND RESTATED CONTRACT MANUFACTURING AGREEMENT Between OSG NORWICH PHARMACEUTICALS, INC. And ALLENDALE PHARMACEUTICALS, INC. For US FDA APPROVED TODAY SPONGEContract Manufacturing Agreement • February 26th, 2007 • Synova Healthcare Group Inc • In vitro & in vivo diagnostic substances • New York
THIS AMENDED AND RESTATED CONTRACT MANUFACTURING AGREEMENT (the “Agreement”) is made this 8th day of March, 2006 (the “Agreement Date”), by and between ALLENDALE PHARMACEUTICALS, INC. (hereinafter known as “Allendale”), a Delaware corporation with a principal place of business at 11 Franklin Turnpike, Allendale, NJ 07401, and OSG NORWICH PHARMACEUTICALS, INC. (hereinafter known as “NPI”), a Delaware corporation with a principal place of business at 6826 State Highway 12, Norwich, NY 13815.
Product and Services Agreement Between Allendale Pharmaceuticals, Inc. and International Paper CompanyProduct and Services Agreement • February 26th, 2007 • Synova Healthcare Group Inc • In vitro & in vivo diagnostic substances • Ohio
This Agreement is made effective as of 3/7/06 (the “Effective Date”), by and between xpedx, a division of International Paper Company (“xpedx”) with an office at 6285 Tri-Ridge Boulevard, Loveland, Ohio, 45140, and Allendale Pharmaceuticals, Inc (“Allendale”) with an office at 73 Franklin Turnpike, Allendale, NJ 07401. Allendale and xpedx are collectively referred to as the “Parties” and, each, singly, as a “Party”.
